drugset / Trial / NCT07421817

Dexamethasone for Prevention of Postoperative Vomiting After Laparoscopic Gynecologic Surgery

NCT07421817 ↗

Completed 120 enrolled Rawalpindi Medical College
RandomizedParallel-groupSingle-blindPrevention

Summary

Postoperative nausea and vomiting (PONV) are common and distressing complications following laparoscopic gynecologic surgery. This randomized controlled trial evaluated whether a single preoperative intravenous dose of dexamethasone reduces postoperative vomiting compared with placebo and explored patient-related risk factors associated with PONV. Women undergoing elective laparoscopic gynecologic surgery were randomly assigned to receive dexamethasone (5 mg IV) or placebo at induction of anesthesia. The primary outcome was the incidence of postoperative vomiting within 24 hours, with secondary outcomes including nausea severity, rescue antiemetic use, and postoperative recovery parameters.

Timeline

Start
2017-10-01
Primary completion
2018-03-31
Completion
2018-03-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexamethasone Small molecule 5 mg Intravenous

Indications

No indication recorded.